The use of anti-CD47 antibodies has shown promising potential in promoting tumor cell elimination through various mechanisms, including the enhancement of phagocytosis by macrophages and the augmentation of non-phagocytic killing by neutrophils and natural killer (NK) cells. Here, CD47 is linked to neoplasm.